Clin2
NCT07224334Possibly a fitRecruiting

How cells talk to adjust insulin for weight

Diabetes (DM)

Treatments studied

Part of Hormones & metabolism clinical trials.

This study looks at how cells in the pancreas communicate to help the body produce enough insulin when you have insulin resistance (weight-related). It tests a peptide to see how this communication works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must be between 18 and 60 years old.
  • Either your BMI is under 27 (lean) or 27 or above (overweight), and your blood sugar and A1c are within certain ranges.
  • You cannot have diabetes, pancreatitis, or a family history of diabetes.
  • No active infections, inflammatory, or mental health issues.
  • You must have good vein access and not be pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07300982Not yet recruiting· Phase 1/Phase 2
Insulin and glucagon action in the liver

This study looks at how insulin and glucagon (hormones that control blood sugar) affect the liver. It may help us understand how the body regulates sugar and could lead to better treatments for diabetes.

Durham, North Carolina
NCT07308184Not yet recruiting· Phase 3
Injectable study treatment for type 2 diabetes

This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.

NCT07186660Recruiting· Phase 2
Studying a new insulin sensitizer for type 1 diabetes

This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.

Charlottesville, Virginia
NCT06967558Recruiting· Phase 2
GLP-1 hormone role in prediabetes

This study looks at how a hormone called GLP-1, made in the pancreas, affects blood sugar levels in people with borderline high blood sugar (prediabetes). It may help find new ways to prevent diabetes.

Rochester, Minnesota
NCT07854886Not yet recruiting
Brain response to a diabetes drug in healthy weight and obesity

This study looks at how a medication that mimics a natural gut hormone affects brain activity related to appetite in people with healthy weight or obesity. It may help researchers find new ways to treat obesity.

Copenhagen
NCT07806695Recruiting· Phase 1
Understanding insulin production in gestational diabetes

This study looks at how the body makes insulin during pregnancy to understand why some women get gestational diabetes. If you join, you'll have some extra blood tests during pregnancy and after birth to help researchers learn more.

Rochester, Minnesota

Hear when a new Diabetes (DM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.